Article

Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells.

Protein Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo 156-8501, Japan.
The Journal of Cell Biology (Impact Factor: 10.82). 04/2011; 193(2):275-84. DOI:10.1083/jcb.201102031
Source: PubMed

ABSTRACT Suppression of autophagy is always accompanied by marked accumulation of p62, a selective autophagy substrate. Because p62 interacts with the Nrf2-binding site on Keap1, which is a Cullin 3-based ubiquitin ligase adapter protein, autophagy deficiency causes competitive inhibition of the Nrf2-Keap1 interaction, resulting in stabilization of Nrf2 followed by transcriptional activation of Nrf2 target genes. Herein, we show that liver-specific autophagy-deficient mice harbor adenomas linked to both the formation of p62- and Keap1-positive cellular aggregates and induction of Nrf2 targets. Importantly, similar aggregates were identified in more than 25% of human hepatocellular carcinomas (HCC), and induction of Nrf2 target genes was recognized in most of these tumors. Gene targeting of p62 in an HCC cell line markedly abrogates the anchorage-independent growth, whereas forced expression of p62, but not a Keap1 interaction-defective mutant, resulted in recovery of the growth defect. These results indicate the involvement of persistent activation of Nrf2 through the accumulation of p62 in hepatoma development.

0 0
 · 
0 Bookmarks
 · 
217 Views
  • [show abstract] [hide abstract]
    ABSTRACT: NRF2 (nuclear factor erythroid 2-related factor 2) is an important transcriptional activator involved in the cellular defense mechanisms against electrophilic and oxidative stress. Recent studies have demonstrated that NRF2 protein is up-regulated in several human malignancies and is associated with worse prognosis of these patients. However, pathological and clinical significance of NRF2 has remained largely unknown in the breast cancer patients. Therefore, in this study, we immunolocalized NRF2 in 106 breast cancer cases. NRF2 immunoreactivity was mainly detected in the nucleus of the breast carcinoma cells and was positive in 44% of the cases, while negligible in normal mammary glands. The NRF2 status was significantly associated with histological grade, Ki-67 labeling index, p62 immunoreactivity and NAD(P)H:quinone oxidoreductase 1 (NQO1) immunoreactivity, and adversely associated with progesterone receptor status. In addition, results of multivariate analysis revealed that NRF2 status was an independent adverse prognostic factor for both recurrence and disease-free survival of the patients. Subsequent in vitro studies also demonstrated that NRF2 expression significantly increased cell proliferation activity of MCF7 and SK-BR-3 breast carcinoma cells. These results suggest that nuclear NRF2 protein is accumulated in the breast carcinoma cells and plays important roles in the proliferation and/or progression of breast carcinoma. Nuclear NRF2 immunoreactivity is therefore considered a potent prognostic factor in breast cancer patients.
    Endocrine Related Cancer 12/2013; · 5.26 Impact Factor
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: Emerging evidence indicate that oxidative stress instigates the formation of ubiquitin (Ub)-aggregates, substrates of autophagy, through a process requiring the ubiquitin binding adaptors p62/SQSTM1 and NBR1. Here, we have investigated the role of p62 and NBR1 in cell survival following hypericin-mediated photodynamic therapy (Hyp-PDT), a procedure known to incite robust ROS-based endoplasmic reticulum (ER) stress and autophagy pathways. We found that Hyp-PDT stimulated the formation of p62- and NBR1-associated Ub-aggregates in normal and cancer cells, which were ultimately removed by autophagy, through a mechanism partially regulated by p38(MAPK). In line with this, genetic or pharmacological p38(MAPK)-inhibition reduced p62 and NBR1 levels and aggregate formation and impaired Nrf2 activation, thus increasing photo-oxidative stress and cell death. p62 deficient cells, or cells lacking p62 along with reduced levels of NBR1 (through siRNA knockdown), also displayed reduced aggregate formation but exhibited attenuated ROS levels, reduced caspase activation and improved survival after Hyp-PDT. The increased resistance to photo-oxidative stress exhibited by cells lacking p62 and/or NBR1 was overruled by the inhibition of the p38(MAPK), which restored cytotoxic ROS levels, thus indicating the relevance of this signal in the control of cell viability. Taken together these findings evidence that in photodynamically-treated cells a p38(MAPK) -regulated pathway coordinates the p62/NBR1-mediated clearance of cytosolic aggregates and mitigates PDT-induced proteotoxicity. They also reveal that a functional p38(MAPK) -Nrf2 signal is required to keep ROS levels in check and protect against PDT-induced proteotoxicity, independently of aggregate formation.
    Free radical biology & medicine 11/2013; · 5.42 Impact Factor
  • [show abstract] [hide abstract]
    ABSTRACT: Studies on gene and/or microRNA (miRNA) dysregulation in the early stages of hepatocarcinogenesis are hampered by the difficulty of diagnosing early lesions in humans. Experimental models recapitulating human hepatocellular carcinoma (HCC) are then used to perform this analysis. We performed miRNA and gene expression profiling to characterize the molecular events involved in the multistep process of hepatocarcinogenesis in the resistant-hepatocyte rat model. A high percentage of dysregulated miRNAs/genes in HCC were similarly altered in early preneoplastic lesions positive for the stem/progenitor cell marker cytokeratin-19, indicating that several HCC-associated alterations occur from the very beginning of the carcinogenic process. Our analysis also identified miRNA/gene-target networks aberrantly activated at the initial stage of hepatocarcinogenesis. Activation of the nuclear factor erythroid related factor 2 (NRF2) pathway and up-regulation of the miR-200 family were among the most prominent changes. The relevance of these alterations in the development of HCC was confirmed by the observation that NRF2 silencing impaired while miR-200a overexpression promoted HCC cell proliferation in vitro. Moreover, T3-induced in vivo inhibition of the NRF2 pathway accompanied the regression of cytokeratin-19-positive nodules, suggesting that activation of this transcription factor contributes to the onset and progression of preneoplastic lesions towards malignancy. The finding that 78% of genes and 57% of dysregulated miRNAs in rat HCC have been previously associated with human HCC as well underlines the translational value of our results. Conclusion: This study indicates that most of the molecular changes found in HCC occur in the very early stages of hepatocarcinogenesis. Among these, the NRF2 pathway plays a relevant role and may represent a new therapeutic target. (Hepatology 2014;58:228–241)
    Hepatology 01/2014; 59(1). · 12.00 Impact Factor

Full-text (2 Sources)

View
36 Downloads
Available from
Jan 31, 2013